跳至主要内容
临床试验/NCT01758172
NCT01758172已完成3 期

Comparison of Hemodynamic and Clinical Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy

Asan Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Mean arterial pressure

研究概览

简要总结

From postoperative patients having undergone pancreaticoduodenectomy;

  1. To compare the hemodynamic parameters from the patient administrated 5% HA and 6% Voluven
  2. To assess the efficacy of the treatment as regards the clinical outcomes and laboratory parameters of the patient
  3. To compare the safety of the 2 intravenous colloids in the patient population

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects should be meet inclusion criteria to participated into the study
  • Age-from 18-75 years adult
  • In the immediate post-operative period of pancreaticoduodenectomy
  • Written informed consent and admitted ICU immediate post-operative patient

排除标准

  • Any patient meeting one or more of the following exclusion criteria may not be entered into the study.
  • Refusal to participate in the study
  • Evidence of pre-operative oliguria (Serum creatinine>1.5mmol/dL)
  • Known Severe congestive heart failure (NYHAIII,IV)
  • Known severe respiratory diseases (PaO2/FiO2 <200)
  • Known coagulopathy (Platelet<100k/mm3, aPTT>70s, PT(INR)>2.5)
  • Known allergy to hydroxyethyl starch
  • Known pregnancy or lactation
  • Has participated in any other clinical trial within 3months
  • Any contraindication to Voluven® or albumin according to their package inserts.

研究组 & 干预措施

Albumin

Active Comparator

albumin was administered to reach CVP up to 7mmHg

干预措施: Albumin (Drug)

6% hydroxyethyl starch 130/0.4

Experimental

6% hydroxyethyl starch 130/0.4 was administered to reach CVP up to 7mmHg

干预措施: 6% hydroxyethyl starch 130/0.4 (Drug)

结局指标

主要结局

Mean arterial pressure

时间窗: post-op 24hr

次要结局

  • Volume(ml) of colloid(post-op 24hrs)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Song Cheol Kim

Principal Investigator

Asan Medical Center

研究点 (1)

Loading locations...

相似试验